Vericel Corp. (VCEL)
34.08
-0.06
(-0.18%)
USD |
NASDAQ |
Apr 06, 16:00
34.09
+0.01
(+0.03%)
After-Hours: 20:00
Vericel SG&A Expense (TTM) : 166.99M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Arbutus Biopharma Corp. | 15.89M |
| Marker Therapeutics, Inc. | 4.185M |
| Moderna, Inc. | 1.018B |
| Krystal Biotech, Inc. | 146.91M |
| Tenaya Therapeutics, Inc. | 24.72M |